{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.7","upperLimit":"7.4","value":"3.60"},{"groupId":"OG001","lowerLimit":"2.2","upperLimit":"79.8","value":"13.27"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"7"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.1","upperLimit":"0.3","value":"0.15"},{"groupId":"OG001","lowerLimit":"0.2","upperLimit":"3.0","value":"0.72"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Cycle 3 day 1 of main study therapy"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.2","upperLimit":"0.5","value":"0.39"},{"comment":"Only 1 participant analyzed","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"49.85"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Time of progression"}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"description":"Expression levels of the free form of soluble CS1 were analyzed at different timepoints from serum samples derived from peripheral blood collection","dispersionType":"Full Range","groups":[{"description":"Participants receiving a combination of Elotuzumab (E) Lenalidomide (L) Dexamethasone (d) in a 28 day cycle","id":"OG000","title":"E-Ld Cohort"},{"description":"Participants receiving a combination of Lenalidomide (L) Dexamethasone (d) in a 28 day cycle","id":"OG001","title":"Ld Cohort"}],"paramType":"MEDIAN","populationDescription":"All treated participants with measurements available either at baseline, at cycle 3 day 1 of study therapy or at time of progression.","reportingStatus":"POSTED","timeFrame":"At baseline (screening), during main study therapy (cycle 3 day 1, up to 64 days) and at time of progression (up to approximately 31 months)","title":"Levels of CS1 Soluble Form (sCS1) in Serum","type":"SECONDARY","unitOfMeasure":"ug/L"}